This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Endourology
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • AMA Interim 2023
      • SUO 2023
      • ESMO 2023
      • IBCN 2023
      • ASTRO 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Beyond the Abstracts
  3. Urologic Oncology

Prostate Cancer

Beyond the Abstracts
Live Cell Molecular Analysis of Primary Prostate Cancer Organoids Identifies Persistent Androgen Receptor Signaling - Beyond the Abstract January 14, 2022
A High-Risk Decipher Biopsy Score is Associated with Conversion from Active Surveillance to Treatment and Treatment Failure in Localized Prostate Cancer - Beyond the Abstract January 5, 2022
Health-Related Quality of Life in Men with Localized Prostate Cancer Treated with Radiotherapy: Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain - Beyond the Abstract January 5, 2022
Detection Rate of 18F-Choline Positron Emission Tomography/Computed Tomography in Patients with Non-Metastatic Hormone Sensitive and Castrate Resistant Prostate Cancer - Beyond the Abstract January 3, 2022
Prostate MRI Improves Diagnostic Performance of PSA for High Grade Prostate Cancer - Beyond the Abstract January 3, 2022
A Comparative Study of Anticoagulant/Antiplatelet Therapy Among Men Undergoing Robot-Assisted Radical Prostatectomy: A Prospective Single Institution Study - Beyond the Abstract December 15, 2021
HIFU in Radio-Recurrent Localized Prostate Cancer - Beyond the Abstract December 14, 2021
Disparities in Germline Testing Among Racial Minorities with Prostate Cancer: Bridging Disparities in Germline Testing Among Men with Prostate Cancer - Beyond the Abstract December 7, 2021
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Beyond the Abstract December 6, 2021
Reliability of Serial Prostate Magnetic Resonance Imaging to Detect Prostate Cancer Progression During Active Surveillance: A Systematic Review and Meta-analysis - Beyond the Abstract December 6, 2021
Popularized: Discovered Gene Patterns Can Predict Prostate Cancer Treatment Response - Beyond the Abstract November 16, 2021
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-Resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial - Beyond the Abstract November 2, 2021
Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the CARD Study – Beyond the Abstract October 25, 2021
Prostate-Specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021 - Beyond the Abstract October 25, 2021
Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. - Beyond the Abstract October 20, 2021
A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer - Beyond the Abstract October 20, 2021
A Machine Learning Approach to Predict Progression on Active Surveillance for Prostate Cancer - Beyond the Abstract September 28, 2021
Comparative Analysis of 1152 African-American and European-American Men with Prostate Cancer Identifies Distinct Genomic and Immunological Differences - Beyond the Abstract September 14, 2021
Association of Age with Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance - Beyond the Abstract September 9, 2021
Real-World Safety and Effectiveness of Radium-223 in Japanese Patients with Castration-Resistant Prostate Cancer (CRPC) and Bone Metastasis - Beyond the Abstract September 2, 2021
Page 9 of 51
  • Start
  • Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free